IGF2BP2
Basic information
Region (hg38): 3:185643130-185825042
Links
Phenotypes
GenCC
Source:
- diabetes mellitus, noninsulin-dependent (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IGF2BP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 17 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 2 | 0 |
Variants in IGF2BP2
This is a list of pathogenic ClinVar variants found in the IGF2BP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-185645614-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
3-185649461-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
3-185652112-T-A | Likely benign (May 31, 2018) | |||
3-185657366-T-A | not specified | Uncertain significance (Feb 15, 2023) | ||
3-185658402-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
3-185672560-G-A | not specified | Uncertain significance (Mar 13, 2023) | ||
3-185672570-G-A | not specified | Uncertain significance (Mar 08, 2024) | ||
3-185672579-G-A | not specified | Uncertain significance (Jun 16, 2023) | ||
3-185672603-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
3-185672635-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
3-185672660-T-A | not specified | Uncertain significance (Feb 13, 2024) | ||
3-185675352-T-C | not specified | Likely benign (Oct 27, 2023) | ||
3-185675798-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
3-185689361-T-C | not specified | Uncertain significance (Mar 12, 2024) | ||
3-185689502-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
3-185689544-G-A | not specified | Uncertain significance (Mar 24, 2023) | ||
3-185689571-T-C | not specified | Uncertain significance (Sep 26, 2023) | ||
3-185689590-A-G | not specified | Uncertain significance (Dec 01, 2022) | ||
3-185692739-C-T | not specified | Uncertain significance (Apr 11, 2023) | ||
3-185793899-G-T | Diabetes mellitus type 2, susceptibility to | risk factor (Jun 01, 2007) | ||
3-185824915-C-T | not specified | Uncertain significance (Dec 08, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IGF2BP2 | protein_coding | protein_coding | ENST00000382199 | 16 | 181318 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.239 | 0.761 | 125732 | 0 | 16 | 125748 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.91 | 200 | 354 | 0.565 | 0.0000205 | 3905 |
Missense in Polyphen | 62 | 147.87 | 0.41928 | 1746 | ||
Synonymous | 0.408 | 136 | 142 | 0.956 | 0.00000914 | 1168 |
Loss of Function | 4.10 | 8 | 33.7 | 0.237 | 0.00000188 | 374 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000906 | 0.0000906 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000881 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000101 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation (By similarity). Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. Binding is isoform-specific. Binds to beta- actin/ACTB and MYC transcripts. {ECO:0000250, ECO:0000269|PubMed:23640942, ECO:0000269|PubMed:9891060}.;
- Pathway
- Metabolism of RNA;Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
(Consensus)
Recessive Scores
- pRec
- 0.216
Intolerance Scores
- loftool
- 0.452
- rvis_EVS
- -0.76
- rvis_percentile_EVS
- 13.33
Haploinsufficiency Scores
- pHI
- 0.809
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Igf2bp2
- Phenotype
Gene ontology
- Biological process
- anatomical structure morphogenesis;negative regulation of translation;regulation of cytokine biosynthetic process;regulation of mRNA stability;mRNA transport
- Cellular component
- nucleus;cytoplasm;cytosol;cytoskeleton
- Molecular function
- RNA binding;mRNA 3'-UTR binding;protein binding;translation regulator activity;mRNA 5'-UTR binding